Elon Musk, the business tycoon behind Neuralink, announced that the U.S. Food and Drug Administration had approved its “first in-human clinical study”.
We are delighted to announce that FDA approval has been received to begin our first human clinical study. The Neuralink team has worked tirelessly in collaboration with FDA to achieve this milestone, which will allow our technology one day to benefit many people. Recruitment has not opened for our clinical study. Soon we’ll have more details about this. We’ll announce more information on this soon!” tweeted.
Congratulations to the Neuralink Team! Musk tweeted.
Congratulations to the Neuralink Team!
— Elon Musk (@Elon Musk)
Neuralink aims to implant brain chips to enable people with disabilities to control computers by using their mind. The company also has long-term ambitions.
Neuralink has stated that its mission is “to create a generalized interface for the brain to restore autonomy today to those who have unmet medical need and unlock human potential in the future.”
The company states that “brain-computer interactions have the potential of changing lives.” “We are currently focusing…